
15 Dec 2021
Why Aptose Biosciences Plunged 45% Yeste ...
Aptose Biosciences (TSX:APT)(NASDAQ:APTO) results for its leukemia drug were met with a poor reaction, sending shares down 45%. Th ...
Get access to the latest news, guides, stock and crypto updates, and take your financial portfolio to the next level.